Fas or ceramide induce apoptosis by Ras-regulated phosphoinositide-3-kinase activation

J Leukoc Biol. 1998 Feb;63(2):253-63. doi: 10.1002/jlb.63.2.253.

Abstract

We demonstrate a rapid and transient activation of phosphoinositide-3-kinase (PI-3-K) by Fas receptor triggering or cellular treatment with synthetic C6-ceramide. The stimulation of PI-3-K is critical for Fas or C6-ceramide-induced programmed cell death because transfection with a transdominant inhibitory PI-3-K construct or pre-treatment with the PI-3-K inhibitor wortmannin almost completely prevented Fas or C6-ceramide-mediated apoptosis. Treatment with the caspase inhibitor Ac-YVAD-cmk or cellular transfection with transdominant inhibitory N17Ras prevented PI-3-K stimulation by Fas, suggesting that Fas activates PI-3-K via caspases and Ras. N17Ras expression also prevented C6-ceramide-initiated PI-3-K stimulation. The notion of a PI-3-K regulation by Ras upon Fas receptor ligation or ceramide treatment is supported by co-immunoprecipitation experiments revealing an activation-dependent association of PI-3-K and Ras.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Androstadienes / pharmacology
  • Apoptosis / drug effects*
  • Cell Line
  • Ceramides / pharmacology*
  • DNA Fragmentation / drug effects
  • Enzyme Activation / drug effects
  • Enzyme Inhibitors / pharmacology
  • Humans
  • Phosphatidylinositol 3-Kinases / metabolism*
  • Phosphoinositide-3 Kinase Inhibitors
  • Proto-Oncogene Proteins p21(ras) / physiology*
  • Signal Transduction
  • Wortmannin
  • fas Receptor / physiology*

Substances

  • Androstadienes
  • Ceramides
  • Enzyme Inhibitors
  • Phosphoinositide-3 Kinase Inhibitors
  • fas Receptor
  • HRAS protein, human
  • Proto-Oncogene Proteins p21(ras)
  • Wortmannin